{"id":"W2494432242","doi":"10.1111/dom.12741","title":"One‐year efficacy and safety of saxagliptin add‐on in patients receiving dapagliflozin and metformin","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Brampton Civic Hospital","funders":"AstraZeneca","keywords":"Saxagliptin; Dapagliflozin; Placebo; Metformin; Medicine; Internal medicine; Adverse effect; Glycated haemoglobin; Type 2 diabetes; Diabetes mellitus; Endocrinology; Sitagliptin; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003036604,0.000596991,0.002004029,0.0004181351,0.0003264383,0.0007814066,0.0003356836,0.0009313328,0.001485691],"category_scores_gemma":[0.003160716,0.0003866006,0.002329902,0.0002904002,0.0003992871,0.0007673381,0.0003902395,0.001833227,0.0002277059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005834525,"about_ca_system_score_gemma":0.0006302032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005775429,"about_ca_topic_score_gemma":0.0007729583,"domain_scores_codex":[0.9991869,0.0003223843,0.00009627237,0.0001401758,0.000131485,0.0001227702],"domain_scores_gemma":[0.9976372,0.0007474953,0.0006179195,0.0001707517,0.000113551,0.0007130786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8694323,0.009312358,0.06275126,0.0002624216,0.002532428,0.0001869323,0.0001336631,0.001037591,0.004228881,0.0000673608,0.000431139,0.04962364],"study_design_scores_gemma":[0.138032,0.3747973,0.473025,0.0001431484,0.005250385,0.0004083075,0.0001844002,0.004168654,0.0027033,0.0002056424,0.0009755233,0.0001062131],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985945,0.0008584433,0.00005743508,0.00004895514,0.00003160245,0.00004667827,0.0000997045,0.000007686142,0.0002550992],"genre_scores_gemma":[0.9986349,0.0004011928,0.000113166,0.0001304103,0.00007280966,0.00005640338,0.0003526563,0.000001746706,0.0002366869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003036604,"threshold_uncertainty_score":0.01605928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009020959823222884,"score_gpt":0.2124561547937064,"score_spread":0.2034351949704836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}